2021 IPO

Jasper Therapeutics Stock

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic

Sign up today and learn more about Jasper Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Jasper Therapeutics Stock

Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.


Funding History

December 2019$35.0M
January 2020$0
January 2020$14.1M


Co-Founder & Vice President Operations & Program Management

Susan Prohaska

Co-Founder & Member Board of Directors

Judith Shizuru M.D.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: